RVMD
Price
$36.32
Change
-$0.15 (-0.41%)
Updated
Apr 15 closing price
Capitalization
6.75B
26 days until earnings call
SKYE
Price
$1.71
Change
+$0.40 (+30.53%)
Updated
Apr 15 closing price
Capitalization
52.97M
Ad is loading...

RVMD vs SKYE

Header iconRVMD vs SKYE Comparison
Open Charts RVMD vs SKYEBanner chart's image
Revolution Medicines
Price$36.32
Change-$0.15 (-0.41%)
Volume$1.15M
Capitalization6.75B
Skye Bioscience
Price$1.71
Change+$0.40 (+30.53%)
Volume$27.44M
Capitalization52.97M
RVMD vs SKYE Comparison Chart
Loading...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVMD vs. SKYE commentary
Apr 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVMD is a StrongBuy and SKYE is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 16, 2025
Stock price -- (RVMD: $36.47 vs. SKYE: $1.31)
Brand notoriety: RVMD and SKYE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVMD: 74% vs. SKYE: 86%
Market capitalization -- RVMD: $6.75B vs. SKYE: $52.97M
RVMD [@Biotechnology] is valued at $6.75B. SKYE’s [@Biotechnology] market capitalization is $52.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVMD’s FA Score shows that 1 FA rating(s) are green whileSKYE’s FA Score has 1 green FA rating(s).

  • RVMD’s FA Score: 1 green, 4 red.
  • SKYE’s FA Score: 1 green, 4 red.
According to our system of comparison, both RVMD and SKYE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVMD’s TA Score shows that 5 TA indicator(s) are bullish while SKYE’s TA Score has 4 bullish TA indicator(s).

  • RVMD’s TA Score: 5 bullish, 3 bearish.
  • SKYE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RVMD is a better buy in the short-term than SKYE.

Price Growth

RVMD (@Biotechnology) experienced а +16.15% price change this week, while SKYE (@Biotechnology) price change was -5.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.86%. For the same industry, the average monthly price growth was -13.47%, and the average quarterly price growth was -21.42%.

Reported Earning Dates

RVMD is expected to report earnings on Aug 06, 2025.

SKYE is expected to report earnings on Nov 29, 2023.

Industries' Descriptions

@Biotechnology (+8.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($6.75B) has a higher market cap than SKYE($53M). RVMD YTD gains are higher at: -16.964 vs. SKYE (-39.576). SKYE has higher annual earnings (EBITDA): -19.64M vs. RVMD (-677.7M). RVMD has more cash in the bank: 2.29B vs. SKYE (67.4M). SKYE has less debt than RVMD: SKYE (191K) vs RVMD (136M). RVMD (0) and SKYE (0) have equivalent revenues.
RVMDSKYERVMD / SKYE
Capitalization6.75B53M12,740%
EBITDA-677.7M-19.64M3,451%
Gain YTD-16.964-39.57643%
P/E RatioN/A3.57-
Revenue00-
Total Cash2.29B67.4M3,396%
Total Debt136M191K71,204%
FUNDAMENTALS RATINGS
SKYE: Fundamental Ratings
SKYE
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVMDSKYE
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 22 days ago
86%
Declines
ODDS (%)
Bearish Trend 12 days ago
77%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NIE21.090.15
+0.72%
Virtus Equity & Convertible Income Fund
PSDM50.700.03
+0.06%
PGIM Short Duration Mlt-Sect Bd ETF
QTOC26.88-0.05
-0.19%
Innovator Growth Accelertd Pls ETF™ Oct
PDBC12.64-0.03
-0.24%
Invesco Optm Yd Dvrs Cdty Stra No K1 ETF
NAIL48.85-1.42
-2.82%
Direxion Daily Hmbldrs&Supls Bull 3X ETF

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with ERAS. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-0.41%
ERAS - RVMD
52%
Loosely correlated
-4.03%
KYMR - RVMD
51%
Loosely correlated
+0.12%
IDYA - RVMD
50%
Loosely correlated
-0.76%
CRNX - RVMD
50%
Loosely correlated
-0.40%
RCKT - RVMD
49%
Loosely correlated
+10.49%
More

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with CRBP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
+30.53%
CRBP - SKYE
46%
Loosely correlated
+3.28%
JANX - SKYE
40%
Loosely correlated
+0.38%
VKTX - SKYE
34%
Loosely correlated
-5.94%
PGEN - SKYE
31%
Poorly correlated
+2.86%
RVMD - SKYE
29%
Poorly correlated
-0.41%
More